This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Analysis of effectiveness
The analysis was based on intention to treat. The primary health outcomes used were alcohol consumption in ounces of ethanol on a typical drinking day in the past month; symptoms of alcohol dependence in the past six months measured by means of a modified 11-item version of the Alcohol Dependence Scale; adverse consequences measured by a nineitem scale; and severity of depression measured by means of a nine-item depression scale from the Health and Daily Living Form. In all the scales used, higher values equated to poorer outcomes. The percentage of individuals in each group who experienced no alcohol consumption, and drinking-related problems in the six months before the three-year follow-up was assessed as a supplementary measure. Groups were shown to be comparable at baseline with respect to age, alcohol consumption in drinking days, number of days intoxicated in the past month, alcohol dependence score, and depression scale score. However, there were significant differences between groups at baseline with respect to income, education years and adverse consequences scale score (the first two figures were lower for the AA group and the latter registered a poorer outcome for the same AA group). In particular the latter was recognised as a prognostic feature.
Effectiveness results
The AA group reported a mean alcohol consumption at 3 years of 3.1 ounces of ethanol, the same value as for the outpatient group. In alcohol dependence the score was 3.2 for both groups and adverse consequences were 2.8 (AA) and 2.6 (non-AA). Depression scale scores were 14.1 for the AA group and 12.6 for the comparator. All these differences were not significant at conventional critical values. The percentage of individuals in each group who experienced no alcohol consumption or drinking-related problems in the six months before the three-year follow-up was 45.9% for the AA group against 34.8% for the control group.
Clinical conclusions
Repeated-measures analysis of variance of five outcomes criteria (those already mentioned plus number of days intoxicated in past month) showed no overall differences between groups. The authors reported that "Both groups experienced significant improvement on all five outcome variables, but the lack of significant group-by-time interactions indicates that the level of improvement was comparable across groups."
Measure of benefits used in the economic analysis
No summary benefit measure was identified in the economic study and only separate clinical outcomes were reported.
Direct costs
Costs were discounted. Broad quantities were reported separately. The costs measured were operating costs and overhead costs. The cost boundary adopted was that of the health care system. The estimation of quantities was based on actual data. The estimation of costs was based on published information from other studies (Holder et al's list). The source of quantities was an inventory filled in by the patients. The quantity of resources was measured between January 1984 and December 1986. The prices referred to 1994. The costs of major surgical procedures related to alcoholism performed within the study period were not taken into account. The detoxification cost was omitted since it was regarded as common to both alternatives.
Statistical analysis of costs
F test was performed to compare groups in terms of costs.
